Oncodesign Company
%20.jpg)
Oncodesign develops anticancer therapies for the treatment of patients with cancer.
Total Funding:
$29.4M
Headquarters:
Others
Funding Status:
IPO
Employee Number:
101-250
Estimated Revenue:
$1M to $10M
Last Funding Type:
Venture - Series Unknown
Technology:
Precision Medicine
Investor Type:
For Profit
Investors Number:
3
Founded Date:
1995-01-01
Industry:
P4 Medicine